Events

Retiro De Equipo (Recall) de Tina-quant Haemoglobin A1c Gen.2 used with COBAS INTEGRA 400 plus analyser, COBAS INTEGRA 800 analyser and cobas c 501/502 modules. An in vitro diagnostic medical device (IVD).

Según Department of Health, Therapeutic Goods Administration, este evento ( retiro de equipo (recall) ) involucró a un dispositivo médico en Australia que fue producido por Roche Diagnostics Australia Pty Limited.

¿Qué es esto?

Una corrección al equipo o acción de retiro tomada por el fabricante para abordar un problema con un dispositivo médico. Los retiros (recalls) ocurren cuando un dispositivo médico está defectuoso, cuando puede poner en riesgo la salud, o cuando simultáneamente está defectuoso y puede poner en riesgo la salud.

Más información acerca de la data acá
  • Tipo de evento
    Recall
  • ID del evento
    RC-2016-RN-01306-1
  • Clase de Riesgo del Evento
    Class II
  • Fecha de inicio del evento
    2016-10-10
  • País del evento
    Australia
  • Fuente del evento
    DHTGA
  • URL de la fuente del evento
    https://apps.tga.gov.au/Prod/sara/arn-detail.aspx?k=RC-2016-RN-01306-1
  • Notas / Alertas
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Notas adicionales en la data
  • Causa
    There is a potential for elevated recoveries from patient samples when using individual c packs of tina-quant hba1c gen.2. this phenomenon has been noticed across multiple lots when the reagent has inadvertently been frozen. this issue may lead to erroneously high hba1c results.
  • Acción
    Users are to ensure the correct storage conditions of +2 to +8 °C are maintained as per IFU and if freezing was suspected, a control measurement should be performed. It was also recommended at this time to perform QC on each reagent cassette. Users are to carry out QC every 24 hr when using the cassette, and with each new cassette. If QC cannot be kept within the specified range, the respective reagent cassette should not be used for further measurement. Consider switching to the Gen.3 reagent which is less susceptible to low temperatures.

Device

Tina-quant Haemoglobin A1c Gen.2 used with COBAS INTEGRA 400 plus analyser, COBAS INTEGRA 800 ana...
  • Modelo / Serial
    Tina-quant Haemoglobin A1c Gen.2 used with COBAS INTEGRA 400 plus analyser, COBAS INTEGRA 800 analyser and cobas c 501/502 modules. An in vitro diagnostic medical device (IVD).Material Number: 04528123190Lots affected: AllARTG Number: 174909
  • Manufacturer
    Roche Diagnostics Australia Pty Limited

Manufacturer

Roche Diagnostics Australia Pty Limited